StratDeck

Two stocks in Healthcare

Johnson & Johnson vs Medtronic: profit, growth, debt and price compared

Medtronic is stronger on 4 of 7 figures: sales growth, price for its expected profit, dividend and price trend. Johnson & Johnson is stronger on 2: profit margin and debt.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Johnson & Johnson's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Johnson & Johnson and Medtronic side by side
Johnson & JohnsonJNJMedtronicMDT
Net marginStronger: 16.2%13.9%
Revenue growth, past year+5.86%Stronger: +13.73%
Debt to equityStronger: 54.8%55.4%
Forward P/E23.5×Stronger: 15.7×
Dividend yield1.94%Stronger: 2.83%
AnalystsBuy · 22Buy · 26
From its 200-day average+10.2%Stronger: +12.5%

Share price over the past year

  • Johnson & Johnson+36.3%
  • Medtronic−0.1%

18 Nov 202518 Nov 2026

Johnson & Johnson or Medtronic: which is stronger?

  • JNJ

    Which is more profitable?

    Johnson & Johnson keeps more of each sale as profit: 16.2% against 13.9%.

  • MDT

    Which is growing its sales faster?

    Medtronic is growing its sales faster: +13.73% over the past year, against +5.86%.

  • JNJ

    Which has borrowed less?

    Johnson & Johnson has borrowed less: its debt is 54.8% of what its shareholders own, against 55.4% for Medtronic.

  • MDT

    Which costs less for the profit it is expected to make?

    Medtronic costs less for the profit it is expected to make: 15.7× its forward earnings, against 23.5×.

  • MDT

    Which pays more in dividends?

    Medtronic pays more back in dividends for what a share costs: 2.83% a year, against 1.94%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • MDT

    Which is in the stronger price trend?

    Medtronic's price is in the stronger trend: 12.5% above its 200-day average, against 10.2% above.

What each company does

JNJJohnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Reports results on 26 January 2027

MDTMedtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

Reports results on 24 November 2026

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.